IASO Bio and Innovent Present New Data of FUCASO® (Eque

IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023

IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Tongji , Sichuan , China , San Diego , California , Huazhong , Hubei , Shanghai , Nanjing , Jiangsu , Peking , Beijing , American , Chinese , Equecabtagene Autoleucel , Jue Wang , Chunrui Li , Eli Lilly , Innovent Biologics , Adimab Incyte , Innovent Biologics Inc , Md Anderson Cancer Center , American Society Of Hematology , Union Medical College , Tongji Medical College , China National Medical Products Administration , Institute Of Hematology , Chinese Academy Of Medical Sciences , Huazhong University Of Science Technology , American Society , Efficacy Outcomes , Multiple Myeloma , Associate Professor , Tongji Hospital , Huazhong University , Lu Gui Qiu , Blood Diseases Hospital , Chinese Academy , Medical Sciences , Peking Union Medical College , New Drug Application , National Medical Products Administration , Sintilimab Injection , Bevacizumab Injection , Adalimumab Injection , Rituximab Injection , Pemigatinib Oral Inhibitor , Ramucirumab Injection , Selpercatinib Capsules , Autoleucel Injection , Tafolecimab Injection , Cancer Center ,